David Brook
academic0.0Global Dominance: 0.00%
David Brook collaborated with Peter Singer on modeling the effects of global access to GLP-1 medicines, which highlight the potential to save millions of lives annually from diabetes and obesity-related complications.
Power0
Reach0
Collect
Not in the pool (under ¢1).
Recent news mentions
In a preprint estimate in collaboration with David Brook, Dr. Singer modelled the effects of global access to these GLP-1 medicines.
Canadians can benefit from tumbling prices on weight-loss drugsThe Globe and Mail·
Canada· 2025-09-10
Canada· 2025-09-10
